{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:29:38Z","timestamp":1781850578166,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["BX000820"],"award-info":[{"award-number":["BX000820"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015728","name":"Clinical Science Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MC_PC_20058"],"award-info":[{"award-number":["MC_PC_20058"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015502","name":"Dialysis Clinics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032212","name":"Renown Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006771","name":"Desert Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Genetics and Genomics Advances"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.xhgg.2025.100444","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:11:14Z","timestamp":1745413874000},"page":"100444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypertension increases PPV for polycystic kidney disease in PKD1 and PKD2 variant carriers"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4813-6893","authenticated-orcid":false,"given":"Natalie","family":"Telis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bolze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua H.","family":"Lipschutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon W.","family":"Sweer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamala A.","family":"Pawloski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Grzymski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hajek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Schiabor Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Cirulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xhgg.2025.100444_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.ackd.2009.12.001","article-title":"Diagnosis and screening of autosomal dominant polycystic kidney disease","volume":"17","author":"Pei","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.xhgg.2025.100444_bib2","series-title":"Polycystins and Molecular Basis of Autosomal Dominant Polycystic Kidney Disease","author":"Ferreira","year":"2015"},{"key":"10.1016\/j.xhgg.2025.100444_bib3","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic Kidney Disease Diagnosis and Management: A Review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.xhgg.2025.100444_bib4","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol. Dial"},{"key":"10.1016\/j.xhgg.2025.100444_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2369-14-186","article-title":"Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry","volume":"14","author":"Mart\u00ednez","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.xhgg.2025.100444_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12963-017-0123-7","article-title":"Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014)","volume":"15","author":"Fernando","year":"2017","journal-title":"Popul. Health Metr."},{"key":"10.1016\/j.xhgg.2025.100444_bib7","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1093\/ndt\/gfp511","article-title":"The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease","volume":"25","author":"Ahmed","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.xhgg.2025.100444_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1523-1755.2005.00077.x","article-title":"The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease","volume":"67","author":"Jafar","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.xhgg.2025.100444_bib9","first-page":"294","article-title":"Hypertension in autosomal dominant polycystic kidney disease: A clinical and basic science perspective","volume":"2","author":"Ratnam","year":"2010","journal-title":"Int. J. Nephrol. Urol."},{"key":"10.1016\/j.xhgg.2025.100444_bib10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ekir.2019.04.018","article-title":"Intrafamilial Variability of ADPKD","volume":"4","author":"Lanktree","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.xhgg.2025.100444_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ackd.2009.12.004","article-title":"Determinants of renal disease variability in ADPKD","volume":"17","author":"Harris","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.xhgg.2025.100444_bib12","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1681\/ASN.2016040425","article-title":"Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context","volume":"27","author":"Leonhard","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.xhgg.2025.100444_bib13","article-title":"Polygenic risk affects the penetrance of monogenic kidney disease","author":"Khan","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.xhgg.2025.100444_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMra022161","article-title":"Polycystic kidney disease","volume":"350","author":"Wilson","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xhgg.2025.100444_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ekir.2021.09.013","article-title":"PKD1 Compared With PK D2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies","volume":"7","author":"Steele","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.xhgg.2025.100444_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"17","author":"Chapman","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.xhgg.2025.100444_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ndt\/gfx043","article-title":"Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial","volume":"33","author":"Torres","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.xhgg.2025.100444_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.kint.2017.12.002","article-title":"REPRISE: tolvaptan in advanced polycystic kidney disease","volume":"93","author":"Wyatt","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.xhgg.2025.100444_bib19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ekir.2017.07.004","article-title":"Tolerability of aquaretic-related symptoms following tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results from TEMPO 3:4","volume":"2","author":"Devuyst","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.xhgg.2025.100444_bib20","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40264-015-0327-3","article-title":"Clinical pattern of tolvaptan-associated liver injury in subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of clinical trials database","volume":"38","author":"Watkins","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.xhgg.2025.100444_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xhgg.2025.100444_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","article-title":"Exome sequencing and analysis of 454,787 UK Biobank participants","volume":"599","author":"Backman","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xhgg.2025.100444_bib23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41467-020-14288-y","article-title":"Genome-wide rare variant analysis for thousands of phenotypes in over 70,000 exomes from two cohorts","volume":"11","author":"Cirulli","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xhgg.2025.100444_bib24","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nbt.2749","article-title":"Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data","volume":"31","author":"Denny","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xhgg.2025.100444_bib25","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xhgg.2025.100444_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.xhgg.2025.100444_bib27","doi-asserted-by":"crossref","first-page":"D766","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xhgg.2025.100444_bib28","doi-asserted-by":"crossref","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","article-title":"Ensembl 2018","volume":"46","author":"Zerbino","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xhgg.2025.100444_bib30","article-title":"A power-based sliding window approach to evaluate the clinical impact of rare genetic variants","author":"Cirulli","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.xhgg.2025.100444_bib31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.21105\/joss.01317","article-title":"lifelines: survival analysis in Python","volume":"4","author":"Davidson-Pilon","year":"2019","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.xhgg.2025.100444_bib32","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1038\/s41436-021-01293-9","article-title":"Positive predictive value highlights four novel candidates for actionable genetic screening from analysis of 220,000 clinicogenomic records","volume":"23","author":"Schiabor Barrett","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2025.100444_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100012","article-title":"Cardiomyopathy prevalence exceeds 30% in individuals with TTN variants and early atrial fibrillation","volume":"25","author":"Schiabor Barrett","year":"2023","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2025.100444_bib34","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/HYPERTENSIONAHA.110.150722","article-title":"Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States","volume":"55","author":"Crews","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.xhgg.2025.100444_bib35","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","article-title":"Participation bias in the UK Biobank distorts genetic associations and downstream analyses","volume":"7","author":"Schoeler","year":"2023","journal-title":"Nat. Hum. Behav."},{"key":"10.1016\/j.xhgg.2025.100444_bib36","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.xhgg.2025.100444_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2016.135","article-title":"The importance of total kidney volume in evaluating progression of polycystic kidney disease","volume":"12","author":"Grantham","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.xhgg.2025.100444_bib38","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/ndt\/gfp055","article-title":"Relationship of ultrasonographically determined kidney volume with measured GFR, calculated creatinine clearance and other parameters in chronic kidney disease (CKD)","volume":"24","author":"Sanusi","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.xhgg.2025.100444_bib39","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/sj.ki.5002374","article-title":"Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study","volume":"72","author":"Wetzels","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.xhgg.2025.100444_bib40","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1186\/s12889-020-09387-w","article-title":"CKDNET, a quality improvement project for prevention and reduction of chronic kidney disease in the Northeast Thailand","volume":"20","author":"Cha\u2019on","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.xhgg.2025.100444_bib41","series-title":"Polycystic Kidney Disease, Autosomal Dominant","author":"Harris","year":"2022"},{"key":"10.1016\/j.xhgg.2025.100444_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gim.2021.09.009","article-title":"A guidelines-consistent carrier screening panel that supports equity across diverse populations","volume":"24","author":"Johansen Taber","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2025.100444_bib43","series-title":"Lynch Syndrome","author":"Idos","year":"2021"}],"container-title":["Human Genetics and Genomics Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247725000478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247725000478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:34:44Z","timestamp":1762637684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666247725000478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2666247725000478"],"URL":"https:\/\/doi.org\/10.1016\/j.xhgg.2025.100444","relation":{},"ISSN":["2666-2477"],"issn-type":[{"value":"2666-2477","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension increases PPV for polycystic kidney disease in PKD1 and PKD2 variant carriers","name":"articletitle","label":"Article Title"},{"value":"Human Genetics and Genomics Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xhgg.2025.100444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society of Human Genetics.","name":"copyright","label":"Copyright"}],"article-number":"100444"}}